Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 451-475 of 753 matching filings.

Per page
25
Current page
19
4

PRIMARY DOCUMENT

Filing date
04 Dec 2013
Reporting date
02 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Nov 2013
Reporting date
11 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Nov 2013
Reporting date
11 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Nov 2013
Reporting date
11 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Nov 2013
Reporting date
11 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
26 Nov 2013
Reporting date
21 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2013
Reporting date
14 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2013
Reporting date
14 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2013
Reporting date
14 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Nov 2013
Reporting date
14 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-188139

424B3

Filing date
15 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-55104

8-A12G

Filing date
15 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Nov 2013
Reporting date
06 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Nov 2013
Reporting date
06 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Nov 2013
Reporting date
08 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Nov 2013
Reporting date
06 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Oct 2013
Reporting date
28 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Oct 2013
Reporting date
28 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Oct 2013
Reporting date
28 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Oct 2013
Reporting date
28 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

FORM 8-K

Filing date
16 Oct 2013
Reporting date
15 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
08 Oct 2013
Reporting date
02 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Sep 2013
Reporting date
10 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Sep 2013
Reporting date
10 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .